As shown in Figure 7, treatment with shikonin inhibited p-PI3K and p-Akt in a dose dependent manner in both cell lines, suggesting that p-Akt and p-PI3K could be involved in the shikonin-induced inhibition of glioma cells. This evidence concerns the gene AKT1 and central nervous system cancer.